Form 4 for TVGN Tevogen Inc.
Accepted 2026-09-15 20:04:49 ET · period of report 2026-09-11 · accession 0001123292-26-001304 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 20:04 | 2026-09-11 | TVGN | Feike Jeffrey L. | Dir | A - Grant | $0.00 | +75.0K | 131.4K | +133% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | A | A | 75,000 | $0.00 | 131,435 | D | — | — | (F1) Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates. |